These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intrauterine devices: an effective alternative to oral hormonal contraception. Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436 [TBL] [Abstract][Full Text] [Related]
4. Efficiency and acceptability of intrauterine contraceptive devices. Trutko NS Acta Med Hung; 1986; 43(2):103-8. PubMed ID: 3588154 [TBL] [Abstract][Full Text] [Related]
5. The copper-7 intrauterine contraceptive device: 5-year evaluation. Sellors JW Can Med Assoc J; 1981 Oct; 125(7):717-20. PubMed ID: 7326653 [TBL] [Abstract][Full Text] [Related]
6. Postpartum and postabortal insertion of intrauterine contraceptive devices. Martorella LA; Esposito JM J Reprod Med; 1975 Apr; 14(4):178-81. PubMed ID: 1142352 [TBL] [Abstract][Full Text] [Related]
7. [The end of IUD marketing in the United States: what does it mean for American women?]. Forrest JD Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479 [TBL] [Abstract][Full Text] [Related]
8. Postpartum insertion of modified intrauterine devices. Cole LP; Edelman DA; Potts DM; Wheeler RG; Laufe LE J Reprod Med; 1984 Sep; 29(9):677-82. PubMed ID: 6387112 [TBL] [Abstract][Full Text] [Related]
9. [The TCu380 IUD: initial international experimental results with the latest "T" family IUD]. Elia D; Belaisch J Contracept Fertil Sex (Paris); 1985 Sep; 13(9):973-8. PubMed ID: 12267501 [TBL] [Abstract][Full Text] [Related]
10. An audit of intrauterine device usage and outcome in general practice. Presley AP Practitioner; 1980 Oct; 224(1348):1089-91. PubMed ID: 7220438 [TBL] [Abstract][Full Text] [Related]
11. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial. Arowojolu AO; Otolorin EO; Ladipo OA Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202 [TBL] [Abstract][Full Text] [Related]
12. Reappearance of the intrauterine device: a 'user-friendly' contraceptive. Kaunitz AM Int J Fertil Womens Med; 1997; 42(2):120-7. PubMed ID: 9160223 [TBL] [Abstract][Full Text] [Related]
14. A three-year study of the copper-7 minigravigard intrauterine contraceptive device in nulliparous women. Srisupandit S J Med Assoc Thai; 1988 Jun; 71(6):294-7. PubMed ID: 3171448 [TBL] [Abstract][Full Text] [Related]
16. Clinical performance of intrauterine device TCu-380 A in Benghazi, Libyan Arab Jamahiriya. Singh R; al-Amari M East Mediterr Health J; 2000; 6(5-6):1073-82. PubMed ID: 12197330 [TBL] [Abstract][Full Text] [Related]
17. A randomized trial on the clinical performance of Nova T380 and Gyne T380 Slimline copper IUDs. Haugan T; Skjeldestad FE; Halvorsen LE; Kahn H Contraception; 2007 Mar; 75(3):171-6. PubMed ID: 17303485 [TBL] [Abstract][Full Text] [Related]
18. [Copper-silver T: The classic T resuscitated]. Jarvela S; Allonen H Contracept Fertil Sex (Paris); 1986 Jan; 14(1):45-7. PubMed ID: 12341240 [TBL] [Abstract][Full Text] [Related]
19. [Intrauterine contraception with Copper-T and Gravigard. A follow-up study from general practice]. Hellebø R Tidsskr Nor Laegeforen; 1979 Jan; 99(1):27-9. PubMed ID: 760239 [No Abstract] [Full Text] [Related]
20. Factors leading to the removal of the intrauterine implant Gynefix. Bonacho I; Gómez-Besteiro MI; Pita S Eur J Contracept Reprod Health Care; 2002 Sep; 7(3):132-6. PubMed ID: 12428931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]